The AngelHive Platform Launches Today, Providing In-Depth Analysis and Risk Assessment To Investors.
Rotterdam, May 23, 2024 (GLOBE NEWSWIRE) -- AngelHive, an analysis and risk assessment platform for early-stage startups has just launched. Powered by Max Ventures, AngelHive focuses on industry insight and risk assessment, providing detailed reports on startups that have been filtered by an experienced in-house team of analysts.
Investment vehicle, Max Ventures Seed One, forms the foundation of the platform, having led some promising rounds and funded some rising stars of its own.
“As startup investors ourselves, we realised that the time-consuming element of any investment is the due diligence process. We decided to create a space offering curated deal flow where the painstaking due diligence has already been performed by a team of expert investors,” says Toni Grunwald, Managing Partner of AngelHive.
The AngelHive methodology consists of an in-depth analysis with more than 100 data points used to develop an informed report for each startup. The report consists of detailed information based on each category while utilising present-day AI capabilities. This strategy is designed to make the due diligence process more streamlined for both investors and startups, with an average reduction time of 80%.
AngelHive offers a unique selling proposition that differs from other VC reporting firms by combining seed one´s high yield fund management; a system associated with Max Ventures, combined with the Angel Hive´s platform. For startups, AngelHive provides an opportunity to be positioned in front of a network of active investors. AngelHive also hosts events, networking and workshop opportunities to create meaningful connections between investors and startups.
AngelHive has positioned itself as a one-stop-shop for early-stage startup investment in Southern Europe. Its AI-powered platform streamlines the due diligence process for investors, fostering a more efficient investment landscape. By offering in-depth startup analysis alongside investors, support and networking opportunities, AngelHive aims to become the go-to platform for both startups seeking funding and investors looking for high-growth potential ventures.
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17